| |
| | Patent 6,756,229 |
 | | Throughout the specification, the term "xenobiotics or foreign matters in vivo" collectively refers to, e.g., medicaments, food additives, environmental pollutants, chemicals in general, etc. and the term "endogenous substrates" refers to all substances present in vivo. |
 | | Specific examples include identification of an enzyme participating the metabolism of xenobiotics and/or endogenous substrates by analyzing a change in the structure of xenobiotics and/or endogenous substrates upon exposure of a test specimen to the human hepatic carcinoma-derived cultured cell line capable of stably expressing cytochromes P450. |
 | | The hepatotoxicity by the metabolism of xenobiotics and/or endogenous substrates can be analyzed by exposing a test specimen, e.g., to the human hepatic carcinoma-derived cultured cell line capable of stably expressing cytochromes P450 and then observing the expression of cytotoxicity. |
| www.pharmcast.com /Patents100/Yr2004/June2004/062904/6756229_CellLine062904.htm (3316 words) |
|